A Phase II Prospective Trial of Prophylactic Donor Lymphocyte Infusions for the Prevention of Relapse post HSCT in patients with High Risk Myeloid Malignancy

Management

Projet: Research project

Détails sur le projet

StatutTerminé
Date de début/de fin réelle1/1/08 → 6/1/19

Financement

  • Social Sciences and Humanities Research Council of Canada: 21 904,00 $ US

ASJC Scopus Subject Areas

  • Renewable Energy, Sustainability and the Environment
  • Cancer Research
  • Oncology
  • Health(social science)

Accéder au projet